Keyphrases
Europe
100%
Primary Care
100%
Cluster Randomized Trial
100%
Type 2 Diabetes Mellitus (T2DM)
100%
10-year Follow-up
100%
Screen-detected
100%
General Practice
80%
Routine Care
80%
Intensive Care Medicine
80%
Treatment Group
60%
Cardiovascular Risk
60%
Cardiovascular Events
60%
Care Groups
60%
Netherlands
40%
Denmark
40%
Diabetes
40%
Hazard Ratio
40%
Cardiovascular Mortality
40%
Diabetes Management
40%
Medical Research Council
40%
Cardiovascular Outcomes
40%
Multifactorial Treatment
40%
Novo Nordisk
40%
Treatment Risk
40%
University Research
20%
Cambridge
20%
Between-group
20%
No Significant Difference
20%
Between-group Difference
20%
UK Department of Health
20%
UK National Health Service
20%
Leicester
20%
National Health Service
20%
National Institute for Health Research
20%
Population-based
20%
Hemoglobin A1c (HbA1c)
20%
Wellcome Trust
20%
Revascularization
20%
Composite Outcome
20%
All-cause Mortality
20%
Blood Pressure
20%
Health Sciences
20%
Health Technology Assessment
20%
5-year Follow-up
20%
Merck
20%
Nonfatal Myocardial Infarction
20%
Glycaemia
20%
Renal Outcome
20%
Strategic Research
20%
Aarhus
20%
Blood Cholesterol
20%
Health Board
20%
Screening Program
20%
Evaluation Technology
20%
Post-intervention Follow-up
20%
Cardiovascular Morbidity
20%
Intention-to-treat Principle
20%
Nonfatal Stroke
20%
Multiple Risk Factors
20%
Pfizer
20%
Astra
20%
Stepwise Screening
20%
National Boards
20%
GlaxoSmithKline
20%
HemoCue
20%
Lost to Follow-up
20%
SERVUS
20%
Traumatic Amputation
20%
Type 2 Diabetic Patients
20%
Medicine and Dentistry
Primary Health Care
100%
Cluster Randomized Trial
100%
Cardiovascular System
100%
Maturity Onset Diabetes of the Young
100%
Diabetes
66%
General Medicine
66%
Care Group
50%
Cardiovascular Risk
50%
Group Therapy
50%
Hazard Ratio
33%
National Health Service
33%
Medical Research
33%
Screening
16%
Apoplexy
16%
Myocardial Infarction
16%
Hemoglobin A1c
16%
Blood Pressure
16%
Intention-to-Treat Analysis
16%
Identified Patient
16%
Revascularization
16%
All Cause Mortality
16%
Post-Hoc Analysis
16%
Technology Assessment
16%
Health Technology
16%
Patient with Type 2 Diabetes
16%
Traumatic Amputation
16%
Cardiovascular Mortality
16%
Alprenolol
16%
Nursing and Health Professions
Primary Medical Care
100%
General Practice
100%
Non Insulin Dependent Diabetes Mellitus
100%
Care Group
75%
Group Therapy
75%
Cardiovascular Risk
75%
Socialized Medicine
50%
Hazard Ratio
50%
Screening
25%
Post Hoc Analysis
25%
Glucose Blood Level
25%
Hemoglobin A1c
25%
Blood Pressure
25%
Intention to Treat Analysis
25%
Randomization
25%
Heart Infarction
25%
All Cause Mortality
25%
Biomedical Technology Assessment
25%
Patient with Type 2 Diabetes
25%
Alprenolol
25%
Cardiovascular Mortality
25%
Traumatic Amputation
25%
Revascularization
25%
Psychology
Hazard Ratio
100%
Blood Pressure
50%
Myocardial Infarction
50%
Technology Assessment
50%